Laronib 100mg Larotrectinib Capsule In Pakistan

Laronib 100mg Larotrectinib Capsule In Pakistan

Laronib 100 mg Capsules contain larotrectinib, a targeted anticancer medicine used to treat certain cancers with a specific genetic alteration called a neurotrophic tyrosine receptor kinase (NTRK) gene fusion.

Larotrectinib works by blocking TRK proteins that can contribute to cancer cell growth. It may be prescribed for eligible patients with solid tumors that have an NTRK gene fusion, depending on the cancer type, previous treatments, and applicable treatment guidelines.

This medicine is intended for specialist-supervised cancer treatment. Eligibility should be confirmed through appropriate molecular testing and assessment by an oncologist.

Key Benefits

• Targeted Cancer Treatment: Targets abnormal TRK signaling associated with NTRK gene fusions.

• May Help Control Tumor Growth: Can help slow or reduce tumor growth in eligible patients.

• Genetically Guided Therapy: Treatment selection is based on the tumor's molecular profile.

• Multiple Tumor Types: May be an option for certain eligible solid tumors, rather than being limited to one organ.

• Specialist-Directed Care: Allows treatment to be monitored and adjusted by an oncology team according to the patient's response and side effects.

Treatment response varies by patient. Larotrectinib is not appropriate for every cancer, and its use depends on the confirmed genetic alteration and applicable prescribing guidance.

Ingredients

• Active Ingredient: Larotrectinib (as larotrectinib sulfate).

• Strength: 100 mg larotrectinib per capsule, as labelled.

• Capsule Shell: The formulation of the capsule shell and other inactive ingredients may vary by manufacturer. The reference Vitrakvi formulation uses gelatin and titanium dioxide, with printing ink ingredients. Confirm Laronib's exact ingredients from its original packaging.

   

Specifications

Product-specific manufacturer, pack size, and registration details should be confirmed from the Laronib packaging and the DRAP database.

How to Use

1. Take Laronib exactly as prescribed by your oncologist.

2. Swallow the capsule whole with water; do not crush or chew it unless your healthcare professional provides specific instructions.

3. Follow your prescribed dose and schedule. Do not change the dose or stop treatment without consulting your oncologist.

4. If you miss a dose or vomit after taking it, follow the product leaflet or contact your oncology team for instructions.

5. Tell your doctor about all medicines and supplements you use, as interactions may occur.

6. Attend recommended follow-up appointments and blood tests to monitor treatment response and possible side effects.